The investment proposals were approved following recommendations to do so by the foreign investment promotion board (FIPB), headed by economic affairs secretary Shaktikanta Das.
However, eight proposals were rejected, the finance ministry statement said. These included those of Cipla Health and Apollo Hospitals Enterprise.
Also Read
"HDFC Fund proposes to make investments in equity, equity-linked instruments, redeemable preference shares, non-convertible debentures and other debt securities of listed or unlisted investee companies engaged in real estate construction development projects which are permitted under the SEBI AIF Regulations as a Cateqory II AIF," it said.
FIPB also cleared Ageon Religare Life Insurance's proposal worth Rs 560 crore.
The approval was sought for the transfer of shares to Aegon India Holding, thereby raising the foreign shareholding from 26 per cent to 49 per cent.
Among others, Sun Pharma Research Advanced Company's proposal worth Rs 250 crore, Synergia Life Sciences (Rs 40 crore) and the post-facto approval for Aditya Birla Nuvo's Rs 377-crore plan were cleared during a meeting held on September 29.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app